A Phase 2 Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects with Beta Thalassemia
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: beta-thalassemia
-
Age: Between 18 - 65 Years
-
Gender: Male or Female
Recruitment Status
OpenContact the research team to learn more about this study.
Fields marked with asterisk (*) are required